JPRN-UMIN000007370
Completed
未知
The study of protective efficancy of postoprerative wound infection by Juzen-taiho-to after laryngo-tracheal separation - The protective efficancy of postoperative wound infection by Juzen-taiho-to
Tokyo University Pediatric Surgery0 sites24 target enrollmentFebruary 23, 2012
ConditionsDysfunction of larynx and pharynx
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Dysfunction of larynx and pharynx
- Sponsor
- Tokyo University Pediatric Surgery
- Enrollment
- 24
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) The patients of Juzen\-daiho\-to administration befor this study 2\) The patients need preparation with licorice 3\) The patients need preparation with glycyrrhizic acid 4\)Liver dysfunction 5\)The other reasons, which doctor judge inappropriate patient
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
A comparative study on the prophylactic effect of Dexmedetomidine and Paracetamol on intraoperative hemodynamic control and postoperative pain in patients undergoing laparoscopic cholecystectomyIRCT20180115038381N1Arak University of Medical Sciences132
Completed
Phase 3
comparison dexamethasone and meperidine on shiveringIRCT20240221061070N1Esfahan University of Medical Sciences45
Completed
Not Applicable
The prospective study of the preventive effect of supraorbital transcutaneous stimulation using the Cefaly(R) device against frequent episodic migraine and chronic migraineMigraine with and without aura, including chronic migraine (ICHD-3beta 1.1, 1.2.1, or 1.3)JPRN-UMIN000033333Tominaga Hospital100
Active, not recruiting
Phase 1
An Evaluation of Efficacy and Safety of Posterior Juxtascleral Administrations of Anecortave Acetate for Depot Suspension (15 mg or 30 mg) versus Sham Administration in Patients (Enrolled in Study A” or Study B”) at Risk for Developing Sight-Threatening Choroidal Neovascularisation (CNV) Due to Exudative Age-Related Macular Degeneration (AMD). - Anecortave Acetate Risk Reduction Trial (AART)non-exudative age related macular degeneration (dry AMD)EUCTR2005-001598-93-ESAlcon Research Limited2,500
Active, not recruiting
Not Applicable
An Evaluation of Efficacy and Safety of Posterior Juxtascleral Administrations of Anecortave Acetate for Depot Suspension (15 mg or 30 mg) versus Sham Administration in Patients (Enrolled in Study A” or Study B”) at Risk for Developing Sight-Threatening Choroidal Neovascularisation (CNV) Due to Exudative Age-Related Macular Degeneration (AMD) - Anecortave Acetate Risk Reduction Trial (AART)non-exudative age related macular degeneration (dry AMD)EUCTR2005-001598-93-DKAlcon Research Limited2,500